These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 14499904)
1. Structural genomics of Mycobacterium tuberculosis: a preliminary report of progress at UCLA. Goulding CW; Perry LJ; Anderson D; Sawaya MR; Cascio D; Apostol MI; Chan S; Parseghian A; Wang SS; Wu Y; Cassano V; Gill HS; Eisenberg D Biophys Chem; 2003 Sep; 105(2-3):361-70. PubMed ID: 14499904 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology. Terwilliger TC; Park MS; Waldo GS; Berendzen J; Hung LW; Kim CY; Smith CV; Sacchettini JC; Bellinzoni M; Bossi R; De Rossi E; Mattevi A; Milano A; Riccardi G; Rizzi M; Roberts MM; Coker AR; Fossati G; Mascagni P; Coates AR; Wood SP; Goulding CW; Apostol MI; Anderson DH; Gill HS; Eisenberg DS; Taneja B; Mande S; Pohl E; Lamzin V; Tucker P; Wilmanns M; Colovos C; Meyer-Klaucke W; Munro AW; McLean KJ; Marshall KR; Leys D; Yang JK; Yoon HJ; Lee BI; Lee MG; Kwak JE; Han BW; Lee JY; Baek SH; Suh SW; Komen MM; Arcus VL; Baker EN; Lott JS; Jacobs W; Alber T; Rupp B Tuberculosis (Edinb); 2003; 83(4):223-49. PubMed ID: 12906835 [TBL] [Abstract][Full Text] [Related]
4. Structural genomics approach to drug discovery for Mycobacterium tuberculosis. Ioerger TR; Sacchettini JC Curr Opin Microbiol; 2009 Jun; 12(3):318-25. PubMed ID: 19481971 [TBL] [Abstract][Full Text] [Related]
5. Structure-based approaches to drug discovery against tuberculosis. Holton SJ; Weiss MS; Tucker PA; Wilmanns M Curr Protein Pept Sci; 2007 Aug; 8(4):365-75. PubMed ID: 17696869 [TBL] [Abstract][Full Text] [Related]
6. The tuberculosis structural genomics consortium: a structural genomics approach to drug discovery. Musa TL; Ioerger TR; Sacchettini JC Adv Protein Chem Struct Biol; 2009; 77():41-76. PubMed ID: 20663481 [TBL] [Abstract][Full Text] [Related]
7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis: a model system for structural genomics. Smith CV; Sacchettini JC Curr Opin Struct Biol; 2003 Dec; 13(6):658-64. PubMed ID: 14675542 [TBL] [Abstract][Full Text] [Related]
9. The potential impact of structural genomics on tuberculosis drug discovery. Arcus VL; Lott JS; Johnston JM; Baker EN Drug Discov Today; 2006 Jan; 11(1-2):28-34. PubMed ID: 16478688 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach. Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549 [TBL] [Abstract][Full Text] [Related]
11. The TB Structural Genomics Consortium: a decade of progress. Chim N; Habel JE; Johnston JM; Krieger I; Miallau L; Sankaranarayanan R; Morse RP; Bruning J; Swanson S; Kim H; Kim CY; Li H; Bulloch EM; Payne RJ; Manos-Turvey A; Hung LW; Baker EN; Lott JS; James MN; Terwilliger TC; Eisenberg DS; Sacchettini JC; Goulding CW Tuberculosis (Edinb); 2011 Mar; 91(2):155-72. PubMed ID: 21247804 [TBL] [Abstract][Full Text] [Related]
12. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Anishetty S; Pulimi M; Pennathur G Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791 [TBL] [Abstract][Full Text] [Related]
13. The TB structural genomics consortium: providing a structural foundation for drug discovery. Goulding CW; Apostol M; Anderson DH; Gill HS; Smith CV; Kuo MR; Yang JK; Waldo GS; Suh SW; Chauhan R; Kale A; Bachhawat N; Mande SC; Johnston JM; Lott JS; Baker EN; Arcus VL; Leys D; McLean KJ; Munro AW; Berendzen J; Sharma V; Park MS; Eisenberg D; Sacchettini J; Alber T; Rupp B; Jacobs W; Terwilliger TC Curr Drug Targets Infect Disord; 2002 Jun; 2(2):121-41. PubMed ID: 12462144 [TBL] [Abstract][Full Text] [Related]
15. Structural Annotation of the Mycobacterium tuberculosis Proteome. Chandra N; Sandhya S; Anand P Microbiol Spectr; 2014 Apr; 2(2):. PubMed ID: 26105824 [TBL] [Abstract][Full Text] [Related]
16. Structural genomics as an approach towards understanding the biology of tuberculosis. Baker EN J Struct Funct Genomics; 2007 Sep; 8(2-3):57-65. PubMed ID: 17668294 [TBL] [Abstract][Full Text] [Related]
17. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. Gey van Pittius NC; Sampson SL; Lee H; Kim Y; van Helden PD; Warren RM BMC Evol Biol; 2006 Nov; 6():95. PubMed ID: 17105670 [TBL] [Abstract][Full Text] [Related]
18. Structural biology of Mycobacterium tuberculosis proteins: the Indian efforts. Arora A; Chandra NR; Das A; Gopal B; Mande SC; Prakash B; Ramachandran R; Sankaranarayanan R; Sekar K; Suguna K; Tyagi AK; Vijayan M Tuberculosis (Edinb); 2011 Sep; 91(5):456-68. PubMed ID: 21514889 [TBL] [Abstract][Full Text] [Related]
19. Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery. Lou Z; Zhang X Protein Cell; 2010 May; 1(5):435-42. PubMed ID: 21203958 [TBL] [Abstract][Full Text] [Related]
20. High-throughput crystallography at an affordable cost: the TB Structural Genomics Consortium Crystallization Facility. Rupp B Acc Chem Res; 2003 Mar; 36(3):173-81. PubMed ID: 12641474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]